Bharat Biotech completes clinical development for phase-III trials and booster doses for BBV154… EP News Bureau Aug 16, 2022 Data from both phase-III human clinical trials have been submitted for approval to National Regulatory Authorities
Researchers at Technical University of Munich investigate mRNA nanoparticles EP News Bureau Jan 1, 2022 Researchers at the Heinz Maier-Leibnitz Zentrum (MLZ) used the high neutron flux available in Garching to characterise various…
AstraZeneca says its vaccine should be effective against new coronavirus variant Reuters Dec 23, 2020 Drugmakers are scrambling to test their COVID-19 vaccines against the new fast-spreading variant of the virus that is raging in…
